Peptide Therapy for Gut Health in Dubai: BPC-157, KPV and the Gut Capsule Stack Gut health is one of the most searched applications of Peptide therapy, and at IV Wellness Lounge it is supported by a focused trio of options: injectable BPC-157, injectable KPV, and the oral KPV + BPC-157 + LL-37 Capsules stack

Gastrointestinal symptoms are the most common manifestations of tirzepatide overdose and may include: Severe nausea and vomiting : Often persistent and more intense than typical side effects, potentially leading to inability to retain fluids or medications Abdominal pain or cramping : May range from mild discomfort to severe pain, typically in the upper abdomen Diarrhea : Can contribute to dehydration and electrolyte imbalances Loss of appetite : Complete aversion to food, extending beyond normal appetite suppression Metabolic disturbances requiring medical attention: Hypoglycemia : Symptoms include trembling, sweating, rapid heartbeat, confusion, dizziness, hunger, irritability, and in severe cases, loss of consciousness or seizures
Pharmaceutical companies already at the forefront of GLP-1RA development have benefitted from this, while others are making significant investments to enter the weight-loss drugs market
Ibrahim SS, Ibrahim RS, Arabi B, Brockmueller A, Shakibaei M, Busselberg D (2024) The effect of GLP-1R agonists on the medical triad of obesity, diabetes, and cancer
Wegovy contains semaglutide, which helps slow down the digestion process and reduce feelings of hunger by acting as a GLP-1 agonist